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ABSTRACT 
Development of a rodent model for renal cancer and disease development due to 
toxicant exposure is complicated by differences in renal handling of toxicants between 
rodents and humans as well as the tendency of rodents to develop significant background 
spontaneous renal disease that may mimic pre-neoplastic disease or mask more subtle 
lesions. Classical toxicological studies often focus on one toxicant in a genetically 
homogeneous population, despite attempting to model human exposure situations 
involving genetically heterogeneous populations and exposure to mixtures of toxicants. 
Given these challenges, it has become clear that toxicological studies must address the 
effects of genetic variability and the range of sensitivity to toxicity due to this inherent 
variability. Experimental paradigms that assess and control for as many of the intrinsic 
and extrinsic factors influencing renal response to toxicant exposure are also needed. In 
an effort to address these limitations, a mouse model was devised that included genetic 
heterogeneity, mixtures of toxicants at environmentally relevant concentrations, and diet 
that reflects a typical western diet to better reflect the exposure conditions of human 
populations. 
Despite development of a mouse model that more accurately reflects human 
environmental toxicant exposure conditions, no primary renal cell tumors were observed 
in the study. Differences in renal health between exposed and unexposed populations 
were observed as well as increased evidence of renal disease in male mice compared to 
females across the entire study population. In the current study TCE exposure did not 
iii 
cause renal cell tumors nor did it increase renal disease when combined with arsenic 
exposure. Evidence of reduced or equal renal damage from co-exposure was observed in 
some cases, and we speculate that this is due to a threshold effect of damage from a first 
toxicant limiting the ability of a second toxicant to cause damage. Additional studies of 
combined toxicant exposure are needed. 
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Chronic exposure to environmental toxicants has been linked to a number of 
health effects including various cancers and kidney disease (Boffetta, 2004; Kataria et 
al., 2015; Rusyn et al., 2014; Soderland et al., 2010; Van Vleet et al., 2003). The kidney 
is frequently a target organ for toxicants due to its role in filtration of the blood and 
metabolism of exogenous substances (Van Vleet, et al., 2003). Because of this role, it is 
reasonable to expect that exposure to many environmental toxicants would result in 
kidney damage, disease, and possibly cancer. 
Cancers of the kidney and renal pelvis account for 3.8% of all new cancer cases 
in the United States and an annual incidence of 15.6 per 100,000 people (National 
Cancer Institute). Tumors of renal tubular cells, renal cell carcinomas, comprise nearly 
90% of renal malignancies. Malignant tumors of the renal pelvis, which are mainly 
transitional cell carcinomas, account for approximately 10% of renal tumors. 
Nephroblastoma, which is a malignancy of the kidney typically observed in children, 
accounts for only about 1% of renal malignancies. 
The incidence trend for renal cancer has continued to increase from the 1970s 
through the present (National Cancer Institute, 2017), although the cause for this has not 
been determined, and the trend shows evidence of leveling off in recent years. In some 
areas of the country, often overlapping with National Priority List (Superfund) sites, 
renal cancer incidence is higher than the national average. One such location is Onslow 
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County, North Carolina, home to a Superfund Site (Camp Lejeune) contaminated with 
trichloroethylene (TCE) and inorganic arsenic (iAs). According to the State Cancer 
Profiles from the Center for Disease Control and Prevention (CDC) and NCI, Onslow 
County had an annual renal cancer incidence of 21.3 per 100,000 from 2008-2012, well 
above the national average. 
While kidney cancer is the 8th most commonly diagnosed cancer in the United 
States each year (National Cancer Institute), an even larger cause of morbidity and 
mortality is chronic kidney disease (CKD). Many different etiologies can be responsible 
for the initial kidney injury, including environmental toxicants (Kataria, et al., 2015; 
Yang et al., 2010). Kidney disease is progressive, and eventually, regardless of the 
instigating problem, the result is the same: CKD and eventual development of end stage 
kidney disease resulting in the need for hemodialysis and transplant. Consequently, 
kidney diseases are the 9th leading cause of death in the United States (Murphy SL et al., 
2017). 
CKD is characterized by permanent damage and subsequent loss of functional 
nephrons with eventual decline in glomerular filtration rate (a measure of kidney 
function). The CDC estimates that 30 million people, or 15% of the United States 
population has CKD (Centers for Disease Control and Prevention, 2017). Because 
remaining functional nephrons can compensate until about 75% of nephrons are lost, 
almost half of those with severe kidney disease are not aware that they have the disease. 
Due to the lack of clinical signs associated with earlier stages of kidney disease, and the 
lack of sensitive and specific diagnostic screening tests, CKD is often not diagnosed 
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until later stages, when little can be done to treat the disease beyond dialysis and, 
eventually, renal transplant. 
Renal cancers and CKD share some common risk factors including obesity, 
smoking, and hypertension. Exposure to some environmental toxicants, including TCE 
and arsenic, has been established as a risk factor for the development of kidney cancer 
(National Center for Environmental Health, 2016). Recently, studies have linked chronic 
kidney disease with environmental toxicants, especially chronic cumulative exposure. 
However, CKD is multifactorial, and genetic susceptibility and other health conditions 
likely play a large role in the development of this disease (Kataria, et al., 2015; 
Soderland, et al., 2010). 
Because people are often exposed to mixtures of environmental toxicants, it is 
imperative that the effects of combination exposures to environmental toxicants on 
kidney disease and cancer are studied in a model that closely mirrors the conditions that 
humans are likely to encounter. Two common environmental toxicants, trichloroethylene 
(TCE) and inorganic arsenic (iAs), are the focus of this study. 
1.2. Trichloroethylene 
Trichloroethylene (TCE) is a chlorinated solvent that was used heavily as an 
industrial degreaser in the United States starting in the 1900s, in batch cleaning in the 
dry cleaning industry, and as part of household aerosol products including paint strippers 




1970s (Bakke et al., 2007). TCE is still in use, although in much reduced volume, as an 
intermediate in the production of hydrofluorocarbon refrigerant and as a metal degreaser.  
Trichloroethylene is not naturally encountered in the environment, but because of 
its historical wide use and improper disposal, TCE has been found at the majority of the 
current and proposed Superfund sites (Scott et al., 2000), and it is the most commonly 
reported organic groundwater contaminant (National Research Council (U.S.) 
Committee on Human Health Risks of Trichloroethylene., 2006). According to the 
Agency for Toxic Substances and Disease Registry (ATSDR), 4.5-18% of US drinking 
water sources tested by the EPA contain detectable levels of TCE (Agency for Toxic 
Substances and Disease Registry, 2014). According to the most recent data available, in 
2009-2013 an estimated 53 million people lived within a 3-mile radius of a Superfund 
site (U.S. EPA Office of Solid Waste and Emergency Response Estimate, 2015). 
Proximity to a Superfund site does not necessarily mean an increased risk of health 
effects due to the difference in contaminants and containment. Even so, the number of 
people living near Superfund sites does highlight the potential for exposure to 
environmental toxicants, especially should containment or mitigation efforts be 
insufficient.  
The majority of TCE used in the United States today evaporates into the air, and 
its half-life in air is approximately 7 days (Agency for Toxic Substances and Disease 
Registry, 2014). Unfortunately, TCE has high mobility in soil and through this route can 
contaminate groundwater before evaporation can disperse it. Once in underground water 
sources, TCE may persist because it is slow to degrade in the underground environment 
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(Agency for Toxic Substances and Disease Registry, 2014). TCE has also been detected 
in marine sediments as well as marine invertebrates and mammals, and some foods. In 
fact, butter and margarine are foods with the highest reported mean concentration of 
TCE at 73.6 ppb (Environmental Protection Agency, 2001). 
A statistically-based national sampling program for TCE in the environment has 
not occurred and so there is no true estimate of the mean level of TCE in any 
environmental medium (Environmental Protection Agency, 2001). Some data regarding 
air levels are available, and generally levels of TCE in the air are low, especially in rural 
areas.  Air levels of TCE are highest in the vicinity of industrial use. 
As previously stated, TCE can be found in groundwater. One potential source for 
much of the groundwater contamination is leaching of TCE through the soil from 
landfills. Several studies have found that landfill leachate can contaminate nearby 
groundwater supplies (Agency for Toxic Substances and Disease Registry, 2014; 
Dewalle et al., 1981; Schultz et al., 1986), and the release of TCE into soil occurs in 
much larger volume than its release into water supplies. While it isn’t known how often 
the level of TCE in groundwater reaches a level that would have toxic effects, wells 
located near areas of TCE use and disposal can be anticipated to have the highest risk of 
contamination (Environmental Protection Agency, 2001). As stated above, when tested 
by the EPA, between 4.5 and 18% of drinking water sources in the United States had 
detectable levels of TCE (Agency for Toxic Substances and Disease Registry, 2014). In 




of samples collected from groundwater. The maximum concentration detected was 159 
ppb, although the median was only 1.1 ppb.  
Workers in industries that utilize TCE, such as degreasing operations, have the 
highest exposure levels to TCE. This exposure is mostly through inhalation, and 
exposure may be as high as 100 ppm. The population at large is more usually exposed 
through contaminated water or food or by contact with consumer products that contain 
TCE (Agency for Toxic Substances and Disease Registry, 2014). TCE has been detected 
in human milk, meaning that breastfeeding babies may be exposed through that route as 
well, if the mother is exposed.  
According to an EPA report on the health risks of TCE, the range of estimated 
exposure (in air) to TCE in the general adult population is 11-33 g/day. In water the 
estimated exposure in the general population is 2-20 g/day. For people who work with 
TCE, the exposure through air ranges from 2232-9489 g/day. People may also be 
exposed to metabolites of TCE in the environment, such as trichloroacetic acid (TCA) 
and dichloroacetic acid (DCA), and these exposures may be much higher than the 
exposure to TCE itself, which may increase the toxic effects of TCE exposure 
(Environmental Protection Agency, 2001).  
Exposure to TCE has been associated with a variety of cancers and disorders, 
including renal cancers and renal injury (Liu et al., 2010; Wartenberg et al., 2000), and it 
has been associated with increased mortality from kidney cancer (Alanee et al., 2015). 
The National Cancer Institute (NCI) estimated that almost 64,000 new cases of kidney 
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and renal pelvis cancer were diagnosed 2017, accounting for approximately 3.8% of all 
new cancer cases in the United States (National Cancer Institute). 
As previously mentioned, populations in some areas have higher incidences of 
renal cancer than in the general population, and these increased incidences are 
sometimes found to correspond to Superfund sites, as is the case with Camp Lejeune, 
mentioned previously. Camp Lejeune was home to a Superfund Site contaminated with 
TCE between the 1950s and 1985 and had an increased incidence of renal tumors 
compared to the national average from 2008-2011. 
Two water supply wells on Camp Lejeune were contaminated; one from an off-
base dry-cleaning operation and one from on-base sources (Bove et al., 2014). While 
both of these contaminated water sources were shut down by 1985, many people 
stationed at this base were exposed to a mixture of toxicants including TCE and 
tetrachloroethylene, a related compound. The maximum detected level of TCE before 
the contaminated wells were shut down was 1400 g/L, while the maximum 
contaminant level (MCL) set by the EPA as the upper limit for TCE in water supplies 
was 5 g/L (Bove, et al., 2014). 
A retrospective cohort study of those stationed at Camp Lejeune between 1979 
and 1985 (during the contamination period) found that there was an elevated risk of 
mortality for those stationed at Camp Lejeune compared to the general population of the 
United States during this period for several causes of death, including cancers of the 
kidney and liver which are targets of TCE (Bove, et al., 2014). Follow up in this study 
only extended through 2008, when 97% of the remaining cohort was still under age 55, 
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leaving comprehensive analysis of the long-term risks from exposure on the base for 
future studies. One limitation of the study was that correlations for the various related 
toxicants were very similar, making it impossible in many cases to separate the effects of 
the individual contaminants. Even so, given the high levels of TCE and related toxicants, 
this study provides further evidence of the association between TCE exposure and 
kidney cancer. 
In addition to its association with the development of RCC, TCE has been 
associated with a variety of other cancers and disorders, including renal injury, cancers 
of hematopoietic tissues, and nervous disorders (Environmental Protection Agency, 
2001; Liu, et al., 2010; National Toxicology  Program, 2014; Wartenberg, et al., 2000). 
Hydrocarbons such as TCE have been associated with the development of CKD 
(Radican et al., 2006; Ravnskov, 2000; Wedeen, 1992). Indeed, Radican et al. found that 
there was a 2-fold greater risk of developing end-stage kidney disease with TCE 
exposure. Additional factors that mediate the severity of TCE toxicity and the 
development of renal cell carcinomas include gender, smoking tobacco, obesity, chronic 
renal failure, hypertension, and exposure to other environmental toxicants, such as 
inorganic arsenic (American Cancer Society, 2015; Lash et al., 2001). 
TCE is lipophilic and rapidly distributes through the body after exposure 
(Cristofori et al., 2015). Its main metabolism is through the cytochrome P450 system 
(mostly CYP2E1) in the liver (Kim et al., 2006; Lock et al., 2006). Here, it is oxidized 
with ultimate production of the main TCE metabolites trichloroethanol (about 30%) and 
trichloroacetic acid (about 10%) (Lock, et al., 2006). An alternate pathway for TCE 
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metabolism occurs in the kidney. In the kidney glutathione (GSH) conjugation occurs, 
forming S-(1,2-dichlorovinyl)-L-cysteine (DCVC) followed by other reactive 
metabolites (Cristofori, et al., 2015; Lock, et al., 2006). This metabolic pathway is minor 
in humans, accounting for metabolism of approximately 0.01% of the TCE exposure 
dose (Cristofori, et al., 2015; Lock, et al., 2006). 
Since mice produce far more oxidative metabolites when exposed to TCE than 
GSH conjugation derived metabolites (Cichocki et al., 2016; Kim et al., 2009; Luo et 
al., 2018; Yoo et al., 2015a; Yoo et al., 2015b), it appears that GSH conjugation is the 
minor pathway for TCE metabolism in mice. While less information is available about 
the relative efficiency of each pathway of TCE metabolism in humans, it appears that, in 
general, humans are far less efficient at metabolizing TCE, leading to potentially longer 
exposure to this toxicant. This difference in efficiency may lead to a longer half-life for 
TCE and its metabolites in humans and might help explain the discrepancies in effects 
between mice and humans, despite similar metabolism of TCE (Kim, et al., 2009). 
Generally, it is believed that metabolites of the oxidation pathway are responsible for 
adverse health effects in the liver and that metabolites derived from GSH conjugation are 
responsible for kidney health effects (Bull, 2000; Lash et al., 2000b). 
1.3. Toxicant Mixtures in Environmental Exposures 
There has recently been increased interest and study on the effects of chemical or 
toxicant mixtures on health outcomes (Kapraun et al., 2017; Pollock et al., 2017), 
particularly for toxicants like TCE whose effects on disease severity and outcome may 
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be mediated by co-exposures in the environment. The effects from mixtures of toxicants 
cannot be predicted based on simple additive assumptions (Berenbaum, 1989), therefore 
studying mixtures of toxicants is important to determine the actual health effects that can 
be expected due to these exposures. 
Typically, toxicology studies use a single strain of rodent and one toxicant at a 
time to assess the effects of a potential toxicant. One of the main groups involved in 
toxicological testing utilizes the B6C3F1 mouse, a hybrid between the C57BL/6 and 
C3H inbred mouse strains, and the Harlan Sprague Dawley rat for carcinogenicity 
studies (King-Herbert et al., 2010). For decades (until 2006), the Fisher 344 rat was used 
in these studies, but use of this strain was discontinued by the NTP due to high 
background incidence of some tumors. This study of toxicants in isolation and in 
genetically homogeneous populations does not model real-life toxicant exposures, as 
people are usually exposed to mixtures of substances and are definitely not genetically 
homogeneous. Inorganic arsenic (iAs) is a prime candidate for studying the interactions 
of multiple toxicants in a more controlled setting than is possible using human 
retrospective studies because it is commonly encountered. Because it is so common, 
arsenic is likely to be part of a mixture of toxicants to which a population might be 
exposed. 
1.4. Arsenic 
Arsenic is a metalloid element with four oxidation states, the two predominant 
states being trivalent arsenite (As III) and pentavalent arsenate (As V) (Iarc Working 
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Group, 2012; National Toxicology  Program, 2014; WHO, 2001). As III is more readily 
absorbed and has been more associated with toxicity (Hindmarsh et al., 1986), although 
metabolism of As IV results in production of As III as well, so both are toxic. Arsenic is 
often found as a compound rather than in pure elemental form. Inorganic arsenic is very 
bioavailable and considered to be of more concern for toxic effects than organic arsenic, 
since organic sources of arsenic are generally present at lower levels (Iarc Working 
Group, 2012). 
Arsenic has been in use for hundreds of years in many different applications 
including, but not limited to, wood preservation, pesticides, mining, and pharmaceuticals 
(Iarc Working Group, 2012; Kimura et al., 2005). Arsenic is a common element in the 
Earth’s crust and can also be released into the environment through anthropogenic 
activities such as mining and burning of fossil fuels. In addition to deposition from these 
sources, large areas of land are contaminated with inorganic arsenic from its historical 
use as a pesticide on agricultural land. 
Water is the primary transport medium for arsenic in the environment, and the 
level and type of arsenic contamination depends on several factors, including 
oxygenation of the water, type of water source, biological activity, and proximity to 
sources of arsenic (WHO, 2001). Levels of arsenic in water can vary from less than 10 
µg /L (averaging 1-2 µg /L in groundwater) up to 5 mg/L near anthropogenic sources or 
3 mg/L in areas with high volcanic rock content. Arsenic contamination of ground water 
occurs in many countries, including areas of the USA in which levels varied from less 
than 1 µg /L to over 3,100 µg /L depending on the area of the country. (Ayotte et al., 
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2003; Burgess et al., 2007; Nielsen et al., 2010; Peters, 2008; Sanders et al., 2012; 
Thundiyil et al., 2007) 
The primary route of exposure for the population at large is through ingestion of 
contaminated water or food.  Daily intake in the general population is typically in the 
range of 20-300 µg /day (WHO, 2001). Occupational exposure through inhalation of 
particulates also occurs in a smaller subset of the population, such as those who prepare 
pressure treated wood or work in metal smelting. 
Inorganic vs. organic arsenic was selected for this study because it is a 
commonly encountered environmental contaminant (National Toxicology  Program, 
2014), and it is considered more biologically important because it is readily absorbed by 
the body and highly reactive whereas organic compounds are poorly absorbed and 
considered relatively innocuous (Chung et al., 2014). Additionally, arsenic can act as a 
co-carcinogen (Germolec et al., 1997; Germolec et al., 1998; Iarc Working Group, 2012; 
Rossman, 2003; Rossman et al., 2001; Rossman et al., 2002; Wang et al., 2002), and as 
previously discussed, combinations of toxicants can have different effects than any 
single toxicant in isolation. 
Arsenic levels in foods and beverages other than drinking water are not regulated 
in the U.S., although there are estimated Minimal Risk Levels (MRLs) for dietary intake.  
MRLs estimate the level of daily exposure over a certain period likely to cause no 
adverse, non-cancer health effects. According to the U.S. Agency for Toxic Substances 
and Diseases Registry (ATSDR), the MRL for chronic (greater than 365 days) arsenic 
exposure is 0.3 µg As/kg body weight per day (Wilson, 2015). MRLs consider only non-
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cancer health effects in the most sensitive populations. Because cancer effects are not 
considered, the possibility remains that chronic exposure to even very low 
concentrations of these toxicants increases the risk of cancer development in susceptible 
individuals, and it is estimated by some that greater than 3 million Americans are 
exposed to levels of iAs above the EPA’s maximum contaminant level of 10 µg /L 
(Naujokas et al., 2013). 
Arsenic intake through diet has historically been considered generally low and of 
relatively minor concern, relative to exposure through drinking water, with regard to 
carcinogenesis (Iarc Working Group, 2012; WHO, 2001). Foods with the highest 
concentrations of arsenic are seafood, rice (including rice cereal), mushrooms, and 
poultry (National Toxicology  Program, 2014). Several recent studies have shown that 
arsenic exposure can exceed proposed limits in populations that consume a large amount 
of rice, especially if the rice is grown in As contaminated water or if they consume 
multiple arsenic-contaminated foods or beverages (Adomako et al., 2009; Meharg et al., 
2008; Rahman et al., 2011; Stone, 2008; Zhu et al., 2008). Arsenic concentration varies 
based on where it is grown and the variety of rice (Rahman, et al., 2011; Signes-Pastor et 
al., 2016; Wilson, 2015). In addition, iAs contamination has been documented in food 
products for children that are derived from rice (Meharg, et al., 2008; Wilson, 2015). 
Arsenic is a known carcinogen affecting skin, lung, liver, urinary bladder, and 
other sites (Chen et al., 1988; National Toxicology  Program, 2014; Smith et al., 1992). 
For example, statistically significant increases in urinary bladder cancer have been 
associated with exposure to 50 μg/L iAs exposure levels in drinking water 
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(Christoforidou et al., 2013). In addition to cancer effects, chronic arsenic exposure has 
been associated with renal damage as measured by proteinuria (Chen et al., 2011), and in 
some studies, with increased risk of developing CKD (Diyabalanage et al., 2017; Hsu et 
al., 2017; Orr et al., 2017; Zheng et al., 2015). As previously mentioned, CKD is of 
concern because its incidence is increasing, and diagnosis is usually made late in the 
course of disease, when little can be done to ameliorate its effects. While kidney damage 
and tumors of the kidney and urinary bladder are associated with arsenic exposure, 
animal models for these cancers are lacking (National Toxicology  Program, 2014). 
While several animal models for CKD exist, because of the diversity of initiating 
causes of CKD and because the models are often strain, age, and/or sex dependent, no 
single model can exactly mirror human CKD (Rabe et al., 2016; Yang, et al., 2010). 
Many factors must be taken into consideration when choosing a rodent model for kidney 
disease, including the previously mentioned strain, sex, and age of the rodents to be used 
as well as mechanism of damage, genetic modifications, and genetic background of 
transgenic models. For example, C57BL/6 mice, the most widely used strain, is 
relatively resistant to hypertension (a factor in the progression of kidney disease) and 
proteinuria (one measure of kidney damage). 
A possible reason for the lack of rodent models that approximate human 
development of kidney disease and cancers after toxicant exposure that can be addressed 
is that mice are extremely efficient at removing xenobiotics, including heavy metals like 
arsenic, from renal tubules via the multidrug resistance pump. Mice have two genes 
(Mdr1a and Mdr1b) coding for the equivalent of the human multidrug resistance (MDR) 
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pump that is involved in extruding various substances from renal tubular cells. Because 
mice are amenable to genetic manipulation, the equivalent multidrug resistance genes in 
mice can be knocked out to study how this affects xenobiotic processing. When 
Mdr1a/1b-/- mice were exposed to arsenic in one study, the mice had increased 
sensitivity to acute arsenic toxicity compared to wild-type mice, and they had higher 
arsenic accumulation in tissues including the kidney (Liu et al., 2002b), better modeling 
that observed in human tissues. 
1.5. Genetic Heterogeneity in Toxicological Testing 
As previously stated, toxicological testing has generally been performed in 
genetically homogeneous rodent populations. A major advantage of this approach is that 
these models provide a well-defined, stable population for study that is readily available 
and has a large amount of historical data established. They are essentially a defined 
reagent, allowing reproducibility. On the other hand, one major disadvantage of this 
approach is that use of a genetically homogeneous study population may mask detection 
of variable responses to toxicants due to genetic variability. 
Several studies have illustrated this problem. A study of acetaminophen using 35 
different inbred strains of mice against the NTP-preferred B6C3F1 hybrid showed that 
there was great variability in hepatotoxicity among strains (Harrill et al., 2009). Thus, 
using a single mouse strain to assess hepatotoxicity might result in erroneous 




(Koturbash et al., 2011; Nguyen et al., 2017; Yoo, et al., 2015b) and nanoparticles 
(Scoville et al., 2015) have found similar differences in response among strains of mice. 
This study examines how chronic, low-dose exposure to mixtures of toxicants 
contributes to the development of adverse health outcomes in a genetically 
heterogeneous population and the genetic factors that influence susceptibility to these 
effects. This work is intended to provide a foundation for development of a model that is 
predisposed to the development of adverse renal health effects after exposure to our 
toxicants of interest: TCE and inorganic arsenic. With this information, the genetic 
factors influencing the susceptibility may be identified, and these genetic factors may 
provide targets for future research, not just in toxicology, but also in the development of 






2. RENAL TUBULAR DAMAGE BUT NOT TUMORIGENESIS RESULTS FROM
LONG-TERM COMBINATORIAL EXPOSURE TO TRICHLOROETHYLENE AND 
INORGANIC ARSENIC IN GENETICALLY HETEROGENEOUS MICE DEFICIENT 
FOR MULTI-DRUG RESISTANCE 
2.1. Overview 
Trichloroethylene (TCE) and inorganic arsenic (iAs) are environmental 
contaminants that can target the kidney. Chronic exposure to TCE is associated with 
increased incidence of renal cell carcinoma, while co-exposure to TCE and iAs likely 
occurs in exposed human populations, such as those near Superfund sites. In order to 
better understand the kidney health consequences of TCE and/or iAs exposure, a 
genetically heterogeneous mouse population derived from FVB/N and CAST/EiJ mouse 
strains and deficient for multidrug resistance genes (Abcb1atm1Bor, Abcb1btm1Bor) was 
chronically exposed for 52-weeks to varying concentrations of TCE and iAs. Although 
no exposure group resulted in primary renal cell tumors, kidneys from exposed mice did 
have significant increases in histologic evidence of renal tubular disease with each 
toxicant alone and with combined exposure. However, no increase in tubular disease was 
observed with combination exposure compared to single toxicant exposure. While this 
model more accurately reflects human exposure conditions, development of primary 
renal tumors observed in humans following chronic TCE exposure was not reproduced, 
even after inclusion of the co-carcinogenic iAs in this model. 
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2.2. Introduction 
Trichloroethylene (TCE) is a chlorinated solvent that has been widely used as an 
industrial degreaser and dry cleaning agent in the past. Due to its wide use and improper 
disposal, TCE has been found at the majority of the current and proposed National 
Priority List (Superfund) sites (Chiu et al., 2006), and is the most commonly reported 
organic groundwater contaminant (National Research Council (U.S.) Committee on 
Human Health Risks of Trichloroethylene., 2006). Exposure to TCE has been associated 
with a variety of cancers and disorders, including renal cancers and renal injury (Liu, et 
al., 2010; Radican, et al., 2006). The most recent estimates from the National Cancer 
Institute (NCI) are that almost 64,000 new cases of kidney and renal pelvis cancer will 
be diagnosed in 2017, which accounts for 3.8% of all new cancer cases in the United 
States and an annual incidence of 15.6 per 100,000 people (Bakke, et al.). In some areas 
of the country, often overlapping with Superfund sites, renal cancer incidence is higher 
than the national average. One such location is Onslow County, North Carolina, home to 
a Superfund Site (Camp Lejeune) contaminated with trichloroethylene (TCE). 
According to the State Cancer Profiles from the Center for Disease Control and 
Prevention (CDC) and NCI, Onslow County had an annual renal cancer incidence of 
21.3 per 100,000 from 2008-2012, well above the national average (Centers for Disease 
Control and Prevention). 
There has recently been increased interest and study on the effects of chemical or 
toxicant mixtures on health outcomes (Kapraun, et al., 2017; Pollock, et al., 2017), 




be mediated by co-exposures in the environment. Inorganic arsenic (iAs) is a prime 
candidate for studying the interactions of multiple toxicants in a more controlled setting 
than is possible using human retrospective studies.  
Inorganic arsenic is a commonly encountered environmental contaminant found 
in soil and groundwater secondary to anthropogenic activities including mining, farming, 
and fossil fuel combustion (National Toxicology  Program, 2014; Naujokas, et al., 
2013). Exposure to iAs is associated with adverse health effects and various cancers in 
humans. For example, statistically significant increases in urinary bladder cancer have 
been associated with exposure to 50 μg/L iAs exposure levels in drinking water 
(Christoforidou, et al., 2013), and chronic exposure to arsenic is associated with the 
development of chronic kidney disease in humans (Diyabalanage, et al., 2017; Hsu, et 
al., 2017; Zheng, et al., 2015). In addition to drinking water, iAs exposure may occur 
through foods and processed beverages such as rice grown in areas with high iAs levels 
(Davis et al., 2012; Gilbert-Diamond et al., 2011; Jackson et al., 2012; Meharg, et al., 
2008; Naujokas, et al., 2013). Consequently, increased concentrations of iAs in rice may 
lead to increased exposure in individuals consuming rice from regions with high levels 
of soil or water iAs contamination (Stone, 2008). Chronic exposure to iAs at levels 
higher than the current EPA maximum contaminant level (10 μg/L) are estimated to 
occur in greater than 3 million people in the United States (Naujokas, et al., 2013), and it 
is reasonable to expect that at least some of the people exposed to iAs will also be 
exposed to other environmental toxicants.  
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Human epidemiological studies on TCE are frequently confounded by exposure 
to other toxicants and multiple cancer risk factors, and they are limited by lack of 
detailed information regarding route, duration, dose, and cumulative exposure to the 
toxicant of interest. While these studies of exposed human populations provide the 
strongest link between toxicant exposure and human disease due to those toxicants, use 
of appropriate mouse models can provide evidence of toxicity and strengthen the case 
for human health effects. 
Toxicological studies classically use a single strain of rodent. The National 
Toxicology Program (NTP) historically used the B6C3F1 hybrid mouse and inbred 
Fisher 344 rat (until 2006), although currently the Harlan Sprague Dawley rat is the 
standard rat strain used in NTP carcinogenicity studies (King-Herbert, et al., 2010), and 
some studies have used other strains of rat. For example, an NTP carcinogenicity study 
on TCE reported in 1988 (TRS 273) utilized four different strains of rat. Due to the long 
history of using standard NTP models in carcinogenicity studies, there is an extensive 
knowledge base, including expected background lesions, and this facilitates cross study 
comparisons, another advantage of the classical toxicological approach. 
NTP carcinogenesis studies for TCE used gavage delivery in corn oil with doses 
determined based on results of a 13-week NTP study (Chhabra et al., 1990), which in 
turn were determined from previous TCE studies (National Cancer Institute, 1976). 
These studies did not reference human exposure data as a basis for dosing in 
experimental animals. In the NTP carcinogenesis study on TCE, a single dose level was 
chosen for TCE in mice based on the results of a previous 13-week toxicity study and 
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not based on known environmental exposure levels. In this study, survival of TCE-
exposed male mice was lower than that of controls, and cytomegaly was reported in 
male and female TCE-exposed mice but none of the vehicle-exposed mice. Increased 
incidence of hepatocellular tumors was observed in mice, but no renal tumors were 
observed. 
For arsenic, classification as a carcinogen is based on evidence of carcinogenicity 
in humans where it is known to cause increased incidence of cancers of the urinary 
bladder and kidneys, as well as other organs depending on route of exposure (National 
Toxicology  Program, 2014). In carcinogenicity studies of arsenic utilizing multiple 
routes of exposure and multiple animal species, no tumors were detected or the results 
were inconclusive in most cases, although increases in urinary bladder cancers and liver 
adenomas were observed in some rat studies, and increased lung tumor number and size 
was observed in the A/J strain (Arnold et al., 2006; Cui et al., 2006; Iarc Working 
Group, 2012; National Toxicology  Program, 2014; Shen et al., 2003; Wang, et al., 
2002). 
While the classic NTP approach has some advantages, it also has substantial 
limitations. Due to the lack of genetic diversity in the models, these models do not 
capture the variation in response to toxicants that is due to genetic heterogeneity in the 
humans they seek to model. They also have the potential to incorrectly predict the 
toxicity of an agent, because different strains of mice may have differing sensitivity to 
toxicants, resulting in over or underestimation of the actual toxicity of an agent.  
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Evaluation of human health outcomes due to chronic low dose toxin exposure 
has been limited by scarcity of research closely mimicking the chronic, low-dose 
exposure to mixtures of toxicants to which humans are exposed. Classical toxicology 
studies investigate one potential toxicant at a time. While this is in keeping with the 
scientific principle of studying only one variable at a time, it does not mirror natural 
exposure, and thus these studies are limited in their ability to predict or model human 
health outcomes. Experimental paradigms that combine human-relevant, chronic, low 
dose exposures to mixtures of environmental toxicants and genetically heterogeneous 
populations as well as nutrition designed to mimic that of exposed human populations 
have the potential to improve the human health relevance of toxicological research. In 
this study, we used two common environmental toxicants in doses designed to mimic 
those identified in the environment, used a genetically heterogeneous population of mice 
to capture genetic variability, and fed a diet whose nutrient profile is similar to the 
typical western diet to better model the nutritional environment in which these toxicants 
would have their effects in the US. 
2.3. Materials and Methods 
2.3.1. Animals 
All housing conditions and procedures were approved by the North Carolina 
State University (NCSU) Institutional Animal Care and Use Committee. Previous work 
in this laboratory, when at NSCU, established a unique F3 mouse population derived 
from two phylogenetically distant inbred mouse strains. The Mus musculus domesticus 
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inbred strain, FVB/N-Abcb1atm1Bor, Abcb1btm1Bor, has a mutation of the multi-drug 
resistance (MDR) transporter genes Abcb1a and Abcb1b, resulting in loss of function of 
the MDR transporter. Mice have an especially active MDR system, while Mdr1a/1b-/- 
mice exposed to arsenic have increased sensitivity to acute arsenic toxicity compared to 
wild-type mice, and had higher arsenic accumulation in tissues including the kidney (Liu 
et al., 2002a), better modeling that observed in human tissues. The M. musculus 
castaneous inbred strain, CAST/EiJ is a wild-derived strain that is genetically distinct 
from the FVB/N strain with a highly divergent polymorphism profile. 
Breeding of mice was performed in house at the NCSU Biological Resource Facility. 
The breeding colony and study mice were maintained in a temperature controlled 
environment at 21+/- 2C on a 12 hour light and 12 hour dark schedule. Female FVB/N-
Abcb1atm1Bor, Abcb1btm1Bor mice (Taconic Biosciences) were crossed with male 
CAST/EiJ mice (Jackson Laboratory) to create an F1 population that was intercrossed to 
create an F2 population. Because only one-quarter of mice in this generation were 
expected to carry the double Abcb1b-/- knockout and a large number of mice with this 
genotype were required for the study population, F2 mice were genotyped to identify 
mice that carried the double knockout of the MDR transporter (Schinkel et al., 1997). 
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These mice were then intercrossed to produce the study population of F3 mice 
homozygous for Abcb1atm1Bor, Abcb1btm1Bor (Figure 2.1). 
Figure 2.1 Breeding Plan.  
Female FVB/N-Abcb1atm1Bor, Abcb1btm1Bor mice were mated to male CAST/EiJ mice. F1 
progeny were intercrossed to produce an F2 population. To obtain an adequate number 
of double knockout mice to enter the study, F2 mice were genotyped and intercrossed to 
maximize the number of F3 mice with the Abcb1/Abcb1b double mutant genotype. 
One hundred F3 mice (fifty males and fifty females) were randomly assigned to 
each of nine exposure groups with one same-sex pup per litter per group to eliminate 
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litter effects and facilitate detection of adverse health outcomes. Exposure dosages were 
calculated as dose equivalents based on human exposure data, and low and high doses 
were selected to be no more than 2 to 6-fold different than actual human exposures. For 
TCE, these values included well water measurements of TCE for the high dose and data 
from the National Health and Nutrition Examination Study (NHANES) for the low dose 
(National Research Council (U.S.) Committee on Human Health Risks of 
Trichloroethylene., 2006). Doses for arsenic were based on the World Health 
Organization (WHO) limit for the low dose and a calculation of arsenic in rice combined 
with average daily intake for the high dose (Stone, 2008). Exposure groups were 
designed to include no, low, and high doses of each toxicant and all possible 
combinations of these categories (Table 2.1). 
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Table 2.1 Toxicant Dose Groups 
Group Dose Ratio (iAs:TCE) iAs Concentration 
(μg/kg food) 
TCE Concentration 
(ppb in water) 
1 None : None 0 0 
2 None : Low 0 5 
3 None : High 0 2850 
4 Low : None 10 0 
5 Low : Low 10 5 
6 Low : High 10 2850 
7 High : None 150 0 
8 High : Low 150 5 
9 High : High 150 2850 
2.3.2. Toxicant Exposure 
Mice, group housed in single sex cages, had ad libitum access to food and water. 
F3 generation mice were weaned at post-natal day 21 onto AIN-93M standard diet 
(Envigo-Teklad Diets). At 6-weeks mice were switched from AIN-93M diet onto an 
American-style diet (Envigo-Teklad Diets) that was designed to be similar to the typical 
American diet with increased kcal from fat, skewed omega 6 to omega 3 fatty acid ratio, 
and deficient folic acid compared to the AIN-93M standard diet. Mice were allowed to 
acclimate to the American diet for 10-14 days before being assigned to a specific 
exposure group. Entry dates into specific treatment cohorts were staggered to minimize 
confounding by calendar date of procedures, with 200-300 F3 mice entering the study 
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every four to five weeks over a 16-week period. TCE (0, 5, or 2850 ppb) was added to 
purified drinking water, prepared fresh weekly, and administered in UV-light protected 
bottles to prevent degradation. iAs (0, 10, or 150 μg/kg as sodium arsenite) was mixed 
into a custom high fat American diet (Envigo-Teklad Diets). All food was replaced 
weekly and stored at 4oC in vacuum-sealed bags to prevent oxidation. Mice were 
maintained on their assigned treatment group for the 52-weeks of toxicant exposure. All 
sample collections and measurements were performed during narrow time windows to 
minimize circadian effects. 
2.3.3. Sample Collection and Histopathologic Examination 
Following 52 weeks of toxicant exposure, mice were euthanized by carbon 
dioxide asphyxiation followed by cervical dislocation. At necropsy, kidneys and other 
organs (liver, lung, heart, and any organs with abnormal findings) were removed, 
weighed, and examined for gross abnormalities. Each kidney was halved longitudinally. 
One half of each kidney was fixed in 10% neutral buffered formalin for 24 hours, 
transferred to 70% ethanol, then routinely processed and paraffin embedded. The 
remaining half was flash frozen in liquid nitrogen for long-term storage. Five 5μm-thick 
serial sections were obtained and the first, third and fifth of these were hematoxylin and 
eosin (H&E) stained for histopathological examination. Light microscopic examination 
of kidney slides was performed by a board certified anatomic pathologist (AP). Each 
slide was randomly assigned a new identifier to mask exposure group from the 




neoplasia or preneoplastic changes. Following this initial examination, one 
representative slide from each individual was examined and scored for histologic 
evidence of renal disease.  
 
2.3.4. Statistical Analysis 
All statistical analyses of tubular disease scores were performed using JMP 13.0. 
Graphs were built in Prism 7 (Mac version 7.0c). Data having non-normal distributions 
were analyzed using the Kruskal-Wallis test. Post-hoc testing was performed using the 
Dunn method for multiple comparisons, which utilizes the Bonferroni adjustment to 
correct for multiple comparisons. The control group for statistical analyses was defined 
as the No iAs/No TCE group.  
 
2.4. Results 
2.4.1. Survival is Not Affected by Exposure Group 
As previously described, one hundred F3 mice (fifty males and fifty females) 
were randomly assigned to each of nine exposure groups with one same-sex pup per 
litter per group to eliminate litter effects and facilitate detection of adverse health 
outcomes. Toxicant exposure occurred for 52 weeks.  
No significant differences were found in a Kaplan-Meier survival analysis 
through the end of the study between any exposure group and the No iAs/No TCE 
(control) group . Log-rank testing of survival showed a significant difference among the 
groups (p=0.047), but subsequent multiple comparisons showed no difference between 
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the control group and any of the treatment groups. Overall, male mice experienced 
greater mortality, regardless of group, by the end of the study (Tables 2.2 and 2.3). 






























3 0 6 0 2 2 1 0 0 
35 
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11 10 18 18 11 8 10 7 15 
52 
weeks 
29 30 31 31 39 25 26 41 39 
Total 
deaths 
43 40 39 49 52 35 37 48 54 
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35 
week 
11 0 10 0 18 0 17 1 8 3 7 1 2 8 6 1 12 3 
52 
week 
17 12 22 8 8 7 23 8 23 16 16 9 17 9 23 18 27 12 
Tot 31 12 32 8 31 8 40 9 33 19 25 10 20 17 29 19 39 15 
2.4.2. Exposure is Associated with Renal Tubular Disease 
While no changes in overall survival to the end of the study were observed, 
significant differences between dose groups in tubular disease score as measured by 
histologic examination were observed. Lesions included in the evaluation were scored 
based on numerical criteria (Table 2.4; Figure 2.2). Diagnoses were based on criteria 
published as part of the International Harmonization of Nomenclature and Diagnostic 
Criteria for Lesions in Rats and Mice (INHAND) Project (Frazier et al., 2012). In cases 
of potential neoplasia of any type, histologic sections of additional organs (lung, liver, or 
heart, as available) from the same individual were examined for evidence of metastasis 
or disseminated disease. Tubular disease lesion scores were determined by summing the 
individual scores in each category, resulting in a total score for each animal between 0 
and 20. 
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Figure 2.2 Examples of Renal Pathology. 
(A) Kidney with tubular dilation (asterisk), degeneration and regeneration. One tubule 
has a necrotic tubular epithelial cell (arrow). (B) Kidney. Example of chronic 
progressive nephropathy lesions. Areas of relatively well demarcated tubular change 
consisting of basophilic tubules with thickened basement membranes. A glomerulus in 
the section is expanded by presumed amyloid. (C) Kidney with lymphoma. (D) Kidney 
with histiocytic sarcoma. Hyaline droplets are a recognized lesion observed in renal 
tubular epithelium of mice with histiocytic sarcoma (inset, lower right).  
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Comparisons were made between each treatment group and the unexposed group. 
As compared to the No iAs/No TCE group (mean score = 1.53), increases in mean 
tubular disease scores were detected in the No iAs/Low TCE (mean score = 3.47, 
p<0.0001), No iAs/High TCE (mean score = 2.83, p=0.0184), Low iAs/No TCE (mean 
score = 3.76, p<0.0001), Low iAs/High TCE (mean score = 3.53, p<0.0001), High 
iAs/No TCE (mean score = 4.00, p<0.0001), and High iAs/High TCE (mean score = 
3.48, p<0.0068) groups (Figure 2.3). In addition, increases in tubular disease scores were 
observed in animals exposed to TCE alone, iAs alone, and in those exposed to both 
toxicants in combination, although there was no increase in average severity of disease 
in those with combination exposure to TCE and iAs compared to those with single 
toxicant exposure (Figure 2.4). 
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Figure 2.3 Tubular Disease Score by Exposure Group. 
Mean (+SE) tubular disease score in each dose group following 52-week exposure to 
TCE, iAs, or both. No As/No TCE group was used as control for comparisons: **** 
p<0.0001; ** p=0.0068; * p=0.0184.  
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Figure 2.4 Tubular Disease Score by Toxicant Exposure Status.  
Mean (+SE) tubular disease score by toxicant exposure or co-exposure following 52-
week exposure to TCE, iAs, or both. No Toxicant group used as control for 
comparisons: **** p<0.0001, *** p=0.0003.  Significantly higher tubular disease scores 
are observed for all toxicant exposed groups, but the tubular disease score is 
significantly decreased in the combination exposure group compared to the iAs only 
group.  
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2.4.3. Exposure and Sex Influence of Non-Renal Neoplasia 
No tubular epithelial neoplasms or pre-neoplastic changes of tubular epithelium 
were observed in the examined sections. Seven instances of infiltrative round cell 
neoplasms (histiocytic sarcoma and presumed lymphoma) affecting the kidney were 
identified (Table 2.5). Of the seven round cell neoplasms identified in the kidneys, six 
were in female mice, and four of the seven were identified in mice with iAs exposure but 
no TCE exposure (Figure 2.3). 
Table 2.5 Renal Neoplasia 
Dose Group Sex Tumor Type Other Affected Organs 
No As/Low TCE F Lymphoma None detected 
Low As/No TCE F Histiocytic sarcoma Liver, Lung 
Low As/No TCE F Histiocytic sarcoma Liver 
Low As/No TCE F Lymphoma Liver, Lung 
Low As/High TCE F Lymphoma Liver 
High As/No TCE M Lymphoma Liver, Lung, Cranial mediastinal mass 
High As/High TCE F Histiocytic sarcoma Lung, Lymph node, Cranial mediastinal mass 
2.5. Discussion 
Developing an accurate rodent model of the development of human TCE-
associated renal tumors, specifically clear cell renal cell carcinoma (ccRCC), has been 
challenging. Toxicological studies generally evaluate toxicants in isolation and in 
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genetically homogeneous populations of rodents, even though this does not reflect the 
genetic variability of exposed human populations or the typical scenario of exposure in 
which multiple toxicants are often encountered together. Response to toxicant exposure 
is governed by many factors including intrinsic (genetic and epigenetic variation, age 
and life stage, sex) and extrinsic factors (co-exposures to other toxicants, nutritional 
state, stressors, dosage, co-morbidities) (Zeise et al., 2013). 
It is becoming increasingly clear that toxicological studies must address the 
effects of genetic variability in the human population and the range of sensitivity to 
toxicity that may result from this inherent variability. In addition, experimental 
paradigms that assess and control for as many of the intrinsic and extrinsic factors as 
possible that affect health outcomes are also needed. In human epidemiological studies, 
there is often a lack of critical detailed information about precise exposure levels, co-
exposures, time period of exposure, or other risk factors. 
In addition to including genetic heterogeneity and nutrition modeled on the 
typical American diet, our study included a second common environmental toxicant, 
iAs, to investigate the potential interactions of two commonly occurring toxicants. 
Arsenic is a known renal toxicant and urinary system carcinogen when exposure occurs 
through drinking water (Christoforidou, et al., 2013), and it is also known to accumulate 
and become concentrated in plant-based food products grown in arsenic-containing 
water (Davis, et al., 2012; Gilbert-Diamond, et al., 2011; Jackson, et al., 2012), which 
provides another avenue for co-exposure to this toxicant. 
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In this study, we analyzed long-term exposure to TCE alone or in combination 
with iAs. Previous studies have shown large variability among strains in metabolism and 
response to TCE (Cichocki et al., 2017), suggesting long-term TCE exposure in 
genetically heterogeneous mice could lead to ccRCC. Surprisingly, there were no 
differences in survival among dose groups; even the control group had a relatively large 
mortality (43% before the end of the study). One factor in lack of survival differences is 
that, in the present study, only renal health was examined. Both TCE and iAs are known 
to have liver and other health effects (Liu, et al., 2010; Singh et al., 2007; Wartenberg, et 
al., 2000), which may have contributed to the similar mortality in the toxicant-exposed 
groups. Another factor to consider is conspecific aggression, relevant to control and 
exposed groups. Aggression among laboratory mice, particularly male mice, is a known 
issue and has proven difficult to reduce in group housing. Many variables are involved in 
aggression between laboratory mice, including but not limited to size of housing, 
number of animals per cage, bedding, shelters, temperature, strain, and stress (Weber et 
al., 2017). Efforts were made in the present study to limit the effects of aggression, such 
as the use of larger than standard cages and limiting exposure to unfamiliar animals. 
Even so, some actions that may limit aggression, for example keeping littermates 
together, could not be implemented in the present study design that was chosen to limit 
litter effects. 
Significant differences in histologic evidence of renal tubular disease were 
observed among the different treatment groups, including increases in tubular disease 
scores between animals exposed to TCE alone, exposed to iAs alone, and those exposed 
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to both toxicants, although no difference in severity was observed in those co-exposed, 
contrary to our expectations. It is possible that damage caused by one toxicant was not 
increased by exposure to a second renal toxicant as the cells already damaged to the 
point of requiring regeneration could not be further damaged by the second toxicant. 
Although the study was designed to increase renal carcinogenic potential, primary renal 
tubular cell neoplasms failed to develop. 
Limitations of animal models for ccRCC due to TCE exposure, including in the 
present study include that the rate of ccRCC in humans is relatively low. Because the 
annual incidence rate in humans is low even in exposed populations, if mice developed 
ccRCC at a similar rate to exposed humans, approximately 5000 animals would be 
needed to detect one case. This makes studying these tumors difficult even in a rodent 
model, due to the large number of individuals required to detect the formation of these 
tumors. Another factor complicating the modeling of this cancer in rodents is that it 
requires long periods of time for tumors to develop, increasing the incidence of age-
associated sporadic lesions, such as chronic progressive nephropathy (CPN), that 
complicate histopathologic interpretation. Further, rodents, especially mice, have a 
higher capacity for metabolism of TCE than humans, (Lash et al., 2000a), making the 
toxic metabolite profile and subsequent organ system pathology potentially different 
from that seen in humans. 
Rats have been the preferred rodent model used to study the effects of TCE 
exposure, but development of CPN is nearly certain in rats as they age, and the 




changes and making interpretation of renal lesions and their significance to risk of tumor 
development in humans difficult. While mice also develop CPN with age, the incidence 
and severity of lesions is generally less than with rats.  
In addition to the limitations of the model discussed above, limitations of this 
study include that mice are not typically used to model renal cancer in toxicology 
studies. Mice have not been documented to develop ccRCC after chronic exposure to 
TCE; however, data on co-exposures to toxicants are lacking, and given the information 
about arsenic’s role as a potential co-carcinogen, it was theorized that inclusion of this 
second toxicant could lead to development of renal tumors in mice. Another limitation is 
that there is limited historical data on background lesions and expected pathology in the 
strains of mice used in this study, and no information is available regarding the crosses 
involving these mouse strains. This can complicate interpretation of pathological 
findings 
Despite these limitations, the authors believe that the current study used a model 
more accurately reflecting human exposure conditions by including multiple toxicants, 
environmentally relevant concentrations, a genetically heterogeneous population, and a 
long period of exposure. Despite the more accurate modeling of human exposure 
conditions, the primary renal tumor development observed in humans following chronic 
TCE exposure was not observed in this study. Renal tubular disease did occur both in 
single TCE- and iAs-exposed groups, as well as combination-exposed groups, although 
the magnitude of tubular diseased was not different between single and combination 
exposed groups.  
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3. TOXICANT EXPOSED AND UNEXPOSED MALE MICE HAVE HIGHER
RENAL DAMAGE BUT RENAL DAMAGE IS NOT INCREASED BY 
COMBINATION EXPOSURE TO TRICHLOROETHYLENE AND INORGANIC 
ARSENIC 
3.1. Overview 
Trichloroethylene (TCE) and inorganic arsenic (iAs) are common environmental 
contaminants that can cause renal disease including renal cell carcinoma with chronic 
exposure to TCE and increased incidence of chronic renal disease from either toxicant. 
Co-exposure to TCE and iAs likely occurs in some human populations, such as those 
near Superfund sites. A genetically heterogeneous mouse population derived from 
FVB/N and CAST/EiJ mouse strains and deficient for multidrug resistance genes 
(Abcb1atm1Bor, Abcb1btm1Bor) was chronically exposed for 52-weeks to varying 
concentrations of TCE and iAs to better understand the effects of these toxicants on the 
development of renal disease following exposure, either in isolation or in combination. 
Kidneys from male mice had increased evidence of renal damage on histologic 
examination, urinalysis, and clinical chemistry. Similar to previously reported results, 
exposed mice had increased evidence of renal tubular disease with each toxicant alone 
and with combined exposure. However, no increase in renal disease was observed with 
combination exposure compared to single toxicant exposure. There was also no effect on 
urinary NGAL observed with toxicant exposure, and there was only moderate 
correlation between urinary NGAL and histopathologic indicators of renal disease. 
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3.2. Introduction 
Kidney diseases are the 9th leading cause of death in the United States (Murphy 
SL, et al., 2017). The CDC estimates that 30 million people, or 15% of the United States 
population has CKD (Centers for Disease Control and Prevention, 2017). The kidney is 
responsible for, among other functions, clearance of waste products from normal body 
processes, maintenance of fluid volume within the body, and metabolism and excretion 
of drugs and environmental toxicants (Perazella, 2009). 
Because the kidney is the primary eliminator of drugs and toxins, it is vulnerable 
to injury from these substances. However, there are many other factors that can increase 
susceptibility to renal damage, including intrinsic factors such as cardiovascular disease, 
diabetes mellitus, sepsis, liver disease, and genetic factors and extrinsic factors including 
environmental contaminants, natural environmental substances, and drugs. The 
development of kidney disease is most often multifactorial (Barnett et al., 2018; 
Perazella, 2009), and the combination of these factors is thought to be responsible for 
much of the variability in kidney disease in response to exposure to renal toxicants. 
Nephrotoxicity requires adequate exposure to an agent capable of causing kidney 
injury (Perazella, 2009). Depending on the degree of injury and the other contributing 
factors, renal injury may be followed by healing and re-establishment of renal function 
or permanent loss of nephrons and ongoing renal disease. (Barnett, et al., 2018) 
Regardless of the source of initial injury and other contributing factors, once a certain 
threshold has been passed, kidney disease is progressive with eventual development of 
chronic kidney disease (CKD) and end stage kidney disease. Because remaining 
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functional nephrons can compensate until about 75% of renal functional mass is lost, 
almost half of those with severe kidney disease are not aware that they have CKD. Due 
to the lack of clinical signs associated with earlier stages of kidney disease, and the lack 
of sensitive and specific diagnostic screening tests, CKD is often not diagnosed until 
later stages, when little can be done to treat the disease beyond dialysis and, eventually, 
renal transplant. 
Renal cancers and CKD share some common risk factors, including obesity, 
smoking, and hypertension. Exposure to some environmental toxicants, including TCE 
and arsenic, has been established as a risk factor for the development of kidney cancer 
(National Center for Environmental Health, 2016). Recently, studies have linked CKD 
with environmental toxicants, especially with chronic cumulative exposure, although, as 
previously mentioned, CKD is multifactorial, and genetic susceptibility and other health 
conditions likely play a large role in the development of this disease (Kataria, et al., 
2015; Soderland, et al., 2010). 
As stated in Chapter 2, people are often exposed to mixtures of environmental 
toxicants, and it is therefore imperative that the effects of combination exposures to 
environmental toxicants on kidney disease and cancer are studied in a model that closely 
mirrors the conditions that humans are likely to encounter. Two common environmental 
toxicants, trichloroethylene (TCE) and inorganic arsenic (iAs), are the focus of this 
study. 
Trichloroethylene is a common environmental toxicant that has been found in the 
majority of current and proposed National Priority List (Superfund) sites and is the most 
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commonly reported organic groundwater contaminant. Large numbers of people live in 
proximity to a Superfund site, although this does not necessarily increase the risk of 
adverse health effects due to differences in contaminants and containment at these sites. 
As previously stated, TCE exposure has been associated with the development of renal 
cell carcinoma (RCC) as well as renal injury (Environmental Protection Agency, 2001; 
Liu, et al., 2010; National Toxicology  Program, 2014; Wartenberg, et al., 2000). 
Specifically, exposure to hydrocarbons including TCE has been associated with the 
development of CKD (Radican, et al., 2006; Ravnskov, 2000; Wedeen, 1992). Indeed, 
Radican et al. found that there was a 2-fold greater risk of developing end-stage kidney 
disease with TCE exposure. 
Arsenic is another common environmental toxicant that can occur naturally in the 
environment or be an environmental pollutant due to human usage of this element in 
applications, including wood preservation, pesticides, mining, and pharmaceuticals. 
High levels of arsenic contamination of ground water occur in many countries, including 
areas of the USA. Chronic arsenic exposure has been associated with renal damage as 
measured by proteinuria (Chen, et al., 2011) and, in some studies, with increased risk of 
developing CKD (Orr, et al., 2017). As previously mentioned, CKD is of concern 
because it is common, and the diagnosis is usually made late in the course of the disease, 
when little can be done to ameliorate its effects. While kidney damage and tumors of the 
kidney and urinary bladder are associated with arsenic exposure, animal models for these 
cancers are lacking (National Toxicology  Program, 2014). 
45 
Environmental exposure to various potential nephrotoxicants is a continuing 
problem (Perazella, 2009). Some of the potential nephrotoxicants include hydrocarbon 
solvents such as TCE and heavy metals such as arsenic. Studies of nephrotoxicants 
typically focus on a single agent. Such studies are necessary to determine specific 
mechanisms involved in toxicity, but they may not accurately reflect real-life situations 
in which multiple toxicants are encountered, comorbidities exist, and differing genetic 
susceptibility is in play (Barnett, et al., 2018). 
The biochemical and molecular mechanisms of renal injury have been the focus 
of many studies. A recent review of mechanisms of acute kidney injury (AKI), which 
may progress to CKD, supports a concept called in-common mechanisms. The idea 
behind the in-common mechanism concept is that even though the agents causing kidney 
injury are different, they will induce similar mechanisms of action that result in kidney 
injury (Barnett, et al., 2018; Hultstrom et al., 2018). Although there is evidence of 
common mechanisms at play, there is also evidence that differing etiologies can have 
unique features as well (Hultstrom, et al., 2018). Particularly in light of the possibility of 
combination exposures to toxicants, it is important to study how the different toxicants 
in combination may cause greater or lesser damage than in single exposure situations. 
In this study, we utilized two common environmental toxicants at doses designed 
to mimic known human exposures to model combination environmental exposures. We 
also used a genetically heterogeneous population of mice to capture genetic variability, 
and we fed a diet whose nutrient profile is similar to the typical western diet to better 




the US. In this chapter we examine evidence of kidney disease induced by TCE and iAs 
via histopathologic examination of the kidney tissue, classical markers of kidney disease 
(urea nitrogen (BUN), creatinine, and proteinuria), and a more recent biomarker of renal 
injury, NGAL.  
 
3.3. Materials and Methods 
3.3.1. Animals and Toxicant Exposure 
Briefly, as described in Chapter 2, a unique F3 mouse population was derived 
from two phylogenetically distant inbred mouse strains: Mus musculus domesticus 
inbred strain, FVB/N-Abcb1atm1Bor, Abcb1btm1Bor, and M. musculus castaneous inbred 
strain, CAST/EiJ.   
Mice, housed in groups of 10 in single sex cages, had ad libitum access to food 
and water. At post-natal day 21, mice were weaned onto AIN-93M standard diet 
(Envigo-Teklad Diets) and at 6-weeks were switched and acclimated to an American-
style diet (Envigo-Teklad Diets) as previously described. Mice were assigned to a 
treatment group and maintained in this group for the duration of the toxicant exposure 
(52 weeks exposure). TCE (0, 5, or 2850 ppb) was added to purified drinking water, 
prepared fresh weekly, and administered in UV-light protected bottles to prevent 
degradation. iAs (0, 10, or 150 μg/kg as sodium arsenite) was mixed into a custom high 
fat American diet (Envigo-Teklad Diets). All sample collections and measurements were 
performed during a narrow time window (approximately 11:00 a.m. to 1:00 p.m.) to 
minimize circadian effects.  
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3.3.2. Sample Collection and Analysis 
3.3.2.1. Serum 
Blood collection was performed prior to the beginning of the toxicant exposure 
study as well as at intermediate times after 19 weeks and 32 weeks of toxicant exposure. 
At the conclusion of the 52-week toxicant exposure, mice were euthanized, and necropsy 
was performed. Immediately following euthanasia, whole blood was obtained via 
cardiac puncture. For all blood collections, blood was allowed to clot for up to 30 
minutes at room temperature in tubes without any additive. The blood was then 
centrifuged at 10,000 x g for 10 minutes to separate serum from erythrocytes and 
leukocytes. Serum was transferred into fresh 1.5 mL clear Eppendorf polypropylene 
tubes and stored at -80°C for seven years for future analysis. Only serum from the 
terminal collection was analyzed for the present study due to low sample volumes and to 
facilitate detection of maximal effects. 
3.3.2.2. Urine 
Urine was collected prior to the beginning of the toxicant exposure study, at 
intermediate times after 19 weeks and 32 weeks of toxicant exposure, and prior to 
euthanasia at the conclusion of each mouse’s participation in the study by use of 
metabolic cages. Mice were individually housed in metabolic cages (Hatteras 
Instruments Inc., Cary NC) for 16 hours with ad libitum access to drinking water. Cages 
collect voided urine and exclude feces via a funnel that channels urine into a 2 mL 
polypropylene collection tube. The collection tube is maintained at 1° to 6°C for the 
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duration of collection. Urine was centrifuged at 10,000 x g for 5 minutes to separate 
particulate matter, 30 L aliquots were made into fresh clear polypropylene tubes, and 
aliquots and original sample tube were stored at -80°C for future analysis. 
3.3.2.3. Histopathology 
As previously described, at the conclusion of the 52-week toxicant exposure, 
mice were euthanized and necropsy was performed. Each kidney was halved 
longitudinally, and one half of each kidney was fixed in 10% neutral buffered formalin 
for 24 hours, transferred to 70% ethanol, then routinely processed and paraffin 
embedded. Five 5μm-thick serial sections were obtained, and the first, third and fifth of 
these were routinely H&E stained for histopathological examination. Each slide was 
randomly assigned a new identifier to mask exposure group from the pathologist. The 
first, third and fifth slides for each individual were examined for neoplasia or 
preneoplastic changes. Following this initial examination, one representative slide from 
each individual was examined and scored for histologic evidence of renal disease. 
3.3.2.4. Clinical Chemistry 
Measurement of serum clinical chemistry values (BUN and creatinine) was 
performed in house using the VetScan VS2 Chemistry Analyzer (Abaxis, Union City, 
CA) and the VetScan Comprehensive Diagnostic Profile Rotor. Serum samples were 
thawed on ice, mixed with an equal volume of 0.9% saline solution to obtain a final 
volume of 100 L, pipetted into the rotor, and analyzed. 
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3.3.2.5. Urine Protein/Creatinine Ratio 
Urine Protein Assay was performed using Pierce Coomassie Plus Bradford Assay 
(Thermo Fisher #23236). A urine sample aliquot was thawed on ice and the assay was 
performed per manufacturer protocol. Briefly, urine samples were diluted with MilliQ 
water (1:500 for females, 1:1000 for males) and pipetted into microplates. The 
Coomassie reagent was brought to room temperature before adding to all wells of the 
plate, and the plate was incubated at room temperature for 10 minutes. Samples were 
measured in duplicate using a microplate reader set at 595 nm. Urine protein 
concentration (mg/dL) was determined based on a standard curve. 
Urine Creatinine measurement was performed using the Creatinine (urinary) 
Colorimetric Assay Kit (Cayman Chemical, Ann Arbor, MI). A urine sample aliquot was 
thawed on ice and the assay was performed according to the manufacturer’s protocol. 
Briefly, urine samples were diluted with MilliQ water and added in duplicate to the wells 
of a microplate. Alkaline picrate solution was added to all wells and incubated on a 
shaker for 10 minutes at room temperature. Initial absorbance was read at 500 nm. Acid 
solution was added to all wells and the plate was incubated for an additional 20 minutes 
at room temperature before the final absorbance measurement. Samples were measured 
in duplicate using a microplate reader set at 500 nm. Urine creatinine concentration 
(mg/dL) was determined based on a standard curve. 
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3.3.2.6. Urine Osmolality 
Urine Osmolality was directly measured by freezing point depression using the 
OsmoPro Multi-Sample Micro-Osmometer (Advanced Instruments, Norwood, MA). 
Briefly, 20 μL of urine was pipetted into an OsmoPro tube, and 20 urine samples were 
analyzed at one time on the instrument. Urine osmolality was reported as mOsm/Kg H20. 
3.3.2.7. Urine Neutrophil Gelatinase Associated Lipocalin (NGAL) 
Urinary Neutrophil Gelatinase Associated Lipocalin (NGAL) measurement was 
performed using the Mouse Lipocalin-2/NGAL Quantikine ELISA kit (R&D Systems). 
Urine aliquots were thawed on ice, diluted in the provided assay buffer, and the assay 
was performed according to the manufacturer’s protocol. Briefly, assay buffer was added 
to all wells of the kit-provided microplate, samples and standards were added in 
duplicate, followed by incubation at room temperature. The plate was aspirated and 
washed, followed by conjugate addition and incubation, substrate incubation in light 
protected conditions, and addition of stop buffer. Samples were measured in duplicate 
using a microplate reader set at 540nm/450nm within 30 minutes of adding the stop 
buffer. Urine NGAL concentration was determined based on a standard curve. Urine 
NGAL concentrations were then normalized to urine creatinine and urine osmolality 
measurements to account for variability in sample concentration. 
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3.3.2.8. Statistical Analysis 
Statistical analysis of the histological tubular disease scoring was performed to 
investigate the effects of TCE dose, iAs dose, and sex on renal damage. Statistical 
analyses were performed by Mr. Donghyuk Lee of the Texas A&M University Statistical 
Collaboration Center and Amie Perry. JMP 13 (JMP®, Version 13) and GraphPad Prism 
8 (Windows version 8.0.1) software was used for all analyses, and figures were 
produced using GraphPad Prism. Data having non-normal distributions were log 
transformed to approximate normality before analysis. The control group for statistical 
analyses was defined as the No iAs/No TCE group when comparisons among groups 
were performed. 
3.4. Results 
3.4.1. Male Mice Have Greater Renal Damage 
Statistical analysis of the histological tubular disease scoring was performed to 
investigate the effects of TCE dose, iAs dose, and sex on renal tubular damage. After 
determining that the data were normally distributed, ANOVA was performed 
(p<0.0001). Further analysis showed that sex (p=0.0006) was a significant factor, and 
that there was a significant interaction between TCE dose and iAs dose (p=0.0005). A t-
test was performed, and, overall, male mice had higher mean total tubular disease scores 
than female mice (Figure 3.1a). 
In addition, male mice in general had higher mean scores for nearly all of the 
assessed individual renal lesions on histologic examination, including: glomerular 
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amyloid/hyaline glomerulopathy (p<0.0001), medullary amyloid or fibrosis (p<0.0001), 
end-stage kidney (p=0.0034), perivascular cellular infiltrate (p=0.005), chronic 
interstitial cellular infiltrate (p=0.028), tubular degeneration and regeneration 
(p=0.0134), tubular single cell necrosis (p=0.0006), pelvic dilation (p<0.0001), infarcts 
(p<0.0001), and hyaline casts (p<0.0001). 
The clinical chemistry parameters assessed had a similar pattern to the histology 
parameters in that male mice generally had higher concentrations of markers associated 
with renal damage. Among the urine and clinical chemistry parameters tested, male mice 
had higher urine protein creatinine ratios (p<0.0001), higher blood urea nitrogen (BUN) 
(p<0.0001), and higher urinary NGAL normalized against creatinine (p=0.0027) (Figure 
3.1b-d). While urinary NGAL normalized against osmolality was numerically higher in 
male mice than female mice, these results did not rise to the level of significance 
(p=0.1654). 
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Figure 3.1 Renal Parameters for Male Versus Female Mice.  
Mean (+SE) A) Tubular damage across all dose groups. Welch’s t test. Mean score with 
standard error. Male n=171; female n=278 (p<0.0001). B) Urine Protein/Creatinine ratio 
across all dose groups. T test following log transformation. Male n = 113, female n = 
233 (p<0.0001). Blood Urea Nitrogen across all dose groups. T test following log 
transformation. Male n = 156, female n = 264 (p<0.0001). NGAL normalized to 
creatinine across all dose groups. T test following log transformation. Male n = 113, 
female n = 233 (p=0.0027). 
3.4.2. Inorganic arsenic does not increase histologic evidence of tubular damage 
in combination with low TCE 
The highest damage score resulted from high arsenic and no TCE exposure, but 
no significant difference was observed between the high As/high TCE condition and the 
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high As/low TCE condition (Figure 3.2). Lowest damage occurred with no toxicants (as 
expected). Interestingly, when the TCE level is high no significant effects were seen 
with the addition of arsenic exposure. When TCE level is low, higher damage was 
observed without Arsenic, and lower damage scores were found when low or high 
arsenic was included. This finding is somewhat perplexing, as we would expect 
combination exposure at any level to result in more damage. It is possible that animals 
that had more extreme damage responses to combined toxicant exposure were lost 
during the exposure period of the study and thus were not available for analysis at the 
termination of the study. This would skew comparisons between animals with single 
toxicant exposure versus those that were exposed to both toxicants, resulting in the 
appearance of no difference between combination and single toxicant exposure or 





Figure 3.2 Interaction Between iAs and TCE Level. 
The highest damage score was observed with high arsenic and no TCE exposure, but 
there was no difference between this and the high As/high TCE condition and the high 
As/low TCE condition. The lowest damage score was observed in the No As/No TCE 
group. With high or no TCE, no change in damage score was observed with arsenic 
exposure. When TCE level was low, higher damage was observed without arsenic, and 




When individual kidney lesion types were examined, those that were more 
common in toxicant-exposed animals (whether single or combination exposure) 
compared to the No As/No TCE control group were: pelvic cellular infiltrates (p = 
0.0005), tubular degeneration and regeneration (p <0.0001), tubular dilation in the 
OSOM (p = 0.0022), pelvic dilation (p = 0.0254), and epithelial vacuolation of tubular 
epithelium (p = 0.0168) (Figure 3.3). Among these lesions, pelvic cellular infiltrates 
were higher in animals exposed to each single toxicant (TCE only p = 0.0064; As only p 
= 0.0033) and combination-exposed animals (p = 0.0274) as compared to the unexposed 
group, but there was no difference between combination-exposed animals and single-
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exposed animals. This pattern held for tubular degeneration and regeneration (TCE only 
mean p <0.0001; As only p <0.0001; combination exposure p =0.0011) except that 
arsenic only exposure resulted in higher tubular degeneration and regeneration score 
compared to combination-exposed animals (p = 0.0004). For tubular dilation of the 
OSOM, both single exposure to TCE (p= 0.0386) and single exposure to iAs (p = 
0.0003) resulted in higher scores for this parameter compared to those not exposed, but 
single exposure to iAs resulted in higher scores for this parameter compared to 
combination exposure (p = 0.0100). For tubular vacuolation, only combination exposure 
resulted in higher scores for this parameter and only in comparison to unexposed animals 
(p = 0.0296). 
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Figure 3.3 Histologic Lesions in Toxicant-Exposed vs. Non-Exposed Mice. 
T-test. Mean (+SE) The individual lesion types that are more common in toxicant-
exposed animals (whether single or combination exposure) compared to the No As/No 
TCE control group are: pelvic cellular infiltrates (p = 0.0005), tubular degeneration and 
regeneration (p <0.0001), tubular dilation in the OSOM (p = 0.0022), pelvic dilation (p = 
0.0254), and epithelial vacuolation of tubular epithelium (p = 0.0168). 
3.4.3. BUN Levels – Correlation to Histology Parameters and Levels Among 
Groups 
Blood urea nitrogen concentrations across the study population were analyzed for 
correlation to the tubular disease score as well as the urinalysis parameters (Table 3.1). 
BUN values were log transformed before Pearson’s correlation testing was performed. 
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Moderate positive linear correlations were observed between (log)BUN and tubular 
score (0.4657), Kidney weight/Body weight ratio (0.4268), (log)NGAL normalized to 
creatinine (0.4349), and (log)NGAL normalized to osmolality (0.3687) (p<0.0001 for 
all). A slight to moderate linear positive correlation was observed between (log)BUN 
and UPC ratio (0.3237). The strongest correlation was found between BUN and tubular 
disease score. 



















1 0.4085 0.4657 0.1700 0.3394 0.2934 
Kidney/Body 
weight ratio 
0.4085 1 0.4267 0.3693 0.3237 0.2522 
(log) BUN 0.4657 0.4267 1 0.2970 0.4349 0.3687 








0.2934 0.2522 0.3687 0.0364 0.9724 1 
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BUN concentrations for single and combination exposed groups were compared 
to the No As/No TCE group after log transformation of the BUN values to improve 
normality. ANOVA followed by the Tukey-Kramer HSD was used for this analysis. In 
this analysis, BUN was higher in single iAs exposed animals compared to unexposed 
animals, but no other differenced were observed. BUN levels for each exposure group 
were analyzed and compared to the No As/No TCE group. Log transformation of BUN 
values was performed to approximate normality before performing ANOVA with post 
hoc testing using Dunnett’s method. Significance was reached only in the Low As/No 
TCE group (p=0.0137) and the High As/No TCE group (p=0.0333) when compared to 
the No As/No TCE group used as the control for this analysis (Figure 3.4). 
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Figure 3.4 BUN Level by Toxicant Exposure Group.  
Mean (+SE) log transformation of the BUN data was performed to attain normality, and 
then ANOVA with post hoc Dunnett’s test for multiple comparisons was performed. The 
No As/No TCE group was used as a control for comparisons. Low As/No TCE 
(p=0.0333) and High As/No TCE (p=0.0137)) have higher BUN levels than the control 
group. 
3.4.4. Urinary NGAL 
The concentration of NGAL in urine was measured. Concentrations of analytes 
in urine may vary depending on the concentration of the urine as well as renal handling 
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of a given analyte, and urine concentration may vary greatly depending upon hydration 
and kidney function. For this reason, urine analytes are normalized against a substance 
that should be relatively constantly excreted, regardless of the concentration of the urine. 
Usually this is done using creatinine because it is easy to measure, and, assuming 
constant production of creatinine and stable glomerular filtration rate, its excretion 
should be constant as it is not reabsorbed or secreted by the renal tubules. The gold 
standard would be to normalize against osmolality because it is a measure of the 
molecules in the urine rather than a surrogate for that measure, such as creatinine. 
However, it is rarely done because of its expense and the relative ease of measuring 
creatinine. 
In the present study, both urine creatinine and urine osmolality were measured 
and used to normalize urine NGAL, and results using the two methods were compared. 
Strong linear correlation (0.9724) was observed between NGAL normalized against 
creatinine and NGAL normalized against osmolality after log transformation (Table 3.1). 
Despite its reported association with tubular damage and slight to moderate 
correlation with the tubular disease score obtained from histologic examination of the 
kidneys (0.3395 for NGAL normalized against creatinine and 0.2934 for NGAL 
normalized against osmolality), no difference was observed in urine NGAL normalized 
against creatinine (p=0.4443) (Figure 3.5) or NGAL normalized against osmolality 
(p=0.4746) (not shown) among the exposure groups, or between single or combination 
exposed animals compared to the No As/No TCE group after log transformation of the 
data. 
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Figure 3.5 Urinary NGAL by Toxicant Exposure Group. 
Mean (+SE) ANOVA with No As/No TCE group used as control. Urinary NGAL 
normalized against urinary creatinine. No significant difference from the No As/No TCE 
group was observed in any of the toxicant-exposure groups. 
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3.4.5. Urine Protein/Creatinine Ratio 
Urine protein creatinine ratio is used to evaluate the level of protein in the urine 
(proteinuria). When UPC ratios are compared between the toxicant-exposure groups and 
the No As/No TCE group used as a control, the UPC ratio is higher only in the Low 
As/High TCE group (p=0.0082) and the High As/No TCE group (p=0.0145) (Figure 
3.6). Male mice across the entire study population had higher UPC values (p<0.0001) 
(Figure 3.7A), which was expected given that male mice are known to have higher levels 
of urinary proteins than female mice physiologically. When UPC levels for the entire 
study population were compared to the UPC levels in the no toxicant control group, the 
magnitude of the increase was higher among toxicant-exposed mice than in the control 
population (Figure 3.7B). 
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Figure 3.6 Urine Protein Creatinine Ratio by Toxicant Exposure Group. 
Mean (+SE) ANOVA with No As/No TCE group used as control. UPC ratio is 
higher only in the Low As/High TCE group (p=0.0082) and the High As/No TCE 
group (p=0.0145).  
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Figure 3.7 UPC Ratio in Male vs. Female Mice 
Mean (+ SE) Welch’s t-test. UPC ratios for male versus female mice across the study 
population. Male mice had significantly higher UPC ratio than female mice both across 
the entire study population (A), and in the no toxicant exposure group (B) but the 
magnitude of the difference was greater in toxicant exposed animals.  
3.5. Discussion 
As discussed in Chapter 2, the development of a rodent model of tumor 
development caused by human exposure to TCE has been challenging. Traditional 
toxicological studies evaluate the effects of toxicants in genetically homogeneous 
populations and in isolation, which does not reflect the human population or exposure 
situation. Another challenge is determining how combination exposure to environmental 
toxicants may affect renal health. 
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The kidney is responsible for many essential bodily functions, and it is 
particularly important in metabolism and excretion of drugs and environmental toxicants 
(Perazella, 2009). Because it is involved in metabolism and excretion of many 
potentially toxic agents, it is particularly vulnerable to injury from these agents. Many 
factors beyond toxicant exposure may affect renal disease, and this, along with the 
relatively late detection of disease in humans, makes it challenging to study. Chronic 
kidney disease has been linked to chronic environmental toxicant exposure (Kataria, et 
al., 2015; Soderland, et al., 2010). Given the likelihood of combination exposure and 
other factors that may affect susceptibility to the development of CKD, it is important 
that the effects of combination toxicant exposure are studied. In this study we analyzed 
the renal effects of long-term combination exposure to TCE with or without iAs. 
Detection of kidney disease in early stages can be difficult. The gold standard of 
kidney function analysis is measurement of glomerular filtration rate (GFR). In the past, 
GFR measurement in mice was a terminal procedure and required multiple blood 
collections. More recently, techniques for measurement of GFR have been developed 
that are not terminal, but these techniques still require multiple blood collections (Rieg, 
2013), reducing the blood volumes available for other analyses and rendering these 
methods impractical for our purposes. Therefore, serum and urinary biomarkers are more 
commonly used to assess kidney function. 
While the use surrogate markers of GFR (BUN and creatinine) is well 
established, they have relatively poor sensitivity and specificity for renal toxicity, and 
they may be affected by non-renal factors such as muscle mass and dehydration. 
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Elevation of urinary NGAL has been reported with tubular injury. It is considered a good 
biomarker for acute kidney injury and is considered promising as a biomarker in CKD 
(Wasung et al., 2015). Because blood volumes available from mice are small, we 
evaluated the UPC and urinary NGAL as more sensitive indicators of kidney damage, 
alongside histopathologic examination of the kidney and the classical biomarker BUN. 
In this study, consistent with previous histology results, some renal biomarkers 
show evidence of renal health effects in some treatment groups, there is no evidence of 
increased renal damage with combination exposure to these toxicants as opposed to 
single exposure to one toxicant. As reported, lower renal biomarker concentrations were 
observed with low TCE and any level of arsenic than with TCE alone and with high 
TCE no increase in damage is observed with arsenic exposure. This finding agrees with 
the unexpected finding from Chapter 2 that TCE and iAs coexposure, regardless of the 
toxicant level involved, did not result in increased histological evidence of renal damage. 
As in that case, we speculate that the degree of damage caused by the first toxicant may 
have caused significant enough damage to cause death of the cells and require a 
regenerative response, precluding additional damage accumulation from the second 
toxicant. 
When histologic parameters were examined, it was found that male mice in 
general had higher levels of tubular damage on the composite tubular disease score. 
They also had higher scores for many of the individual histologic lesions, including 
those not included in the composite tubular disease score, such as glomerular disease. 
This is expected, as male rodents generally have a higher incidence of renal disease, 
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including chronic progressive nephropathy. The reason for this increase in renal disease 
in male rodents is not entirely understood but is well documented. In addition to the 
histologic evidence of renal disease, male mice also had higher UPC ratios, BUN, and 
urinary NGAL levels than female mice, supporting the histological findings. Male mice 
generally do have higher UPC values than females because of higher levels of protein in 
the urine of male mice, primarily the major urinary proteins (MUPS). 
Several individual renal lesions scored on histologic examination of the kidneys 
were increased in animals exposed to either or both toxicants when compared to those in 
the No As/No TCE group. These include pelvic cellular infiltrates (a measure of 
inflammation), as well as tubular degeneration and regeneration, tubular dilation in the 
outer stripe of the outer medulla, and tubular epithelial vacuolation. This is consistent 
with previous findings of higher overall tubular disease score in toxicant exposed 
groups. Among these individual lesions, only tubular epithelial vacuolation was higher 
in animals exposed to both toxicants than in unexposed animals, although no difference 
was observed for this parameter between the combination exposed groups and those 
exposed to only TCE or only iAs. 
Evaluation of urinary NGAL, UPC, and BUN did not show a strong pattern in 
response to toxicant exposure. Urinary NGAL levels were not different in single or 
combination exposed animals across the study, nor in any single exposure group when 
compared to the No As/No TCE group. However, urinary NGAL was higher in male 
mice than in female, consistent with the histologic finding of generally higher evidence 
of renal damage in male mice than in females. Similarly, the UPC ratio was higher in 
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male mice than in female mice, as expected given the generally higher levels of urinary 
proteins in male mice. But, the UPC ratio was only elevated above that in the No As/No 
TCE group in the Low As/High TCE group and the High As/No TCE group. The 
common factor between these groups is As exposure. BUN was higher in male mice as 
well, consistent with the overall pattern seen in male mice, but it was also higher in the 
Low As/No TCE and High As/No TCE group. Like with UPC ratio, the common factor 
was As exposure, and TCE exposure appears to have had little effect on the BUN 
concentration. 
Correlation between the measured parameters was examined. As described, the 
highest correlation, although still only moderate, was observed between the histologic 
tubular disease score and BUN. Similar correlation was observed between BUN and the 
gross measurement of kidney weight/body weight ratio. Tubular disease score and BUN 
also had slight to moderate correlations with urinary NGAL, even though urinary NGAL 
did not reach significance in association with any specific toxicant exposure profile. 
NGAL normalized against creatinine and NGAL normalized against osmolality had 
strong positive correlation, indicating that normalizing against creatinine is likely an 
acceptable normalization method in this study. 
As detailed in Chapter 2, there are significant limitations to this study including 
significant loss of animals before the end of the study (44% of the study population), 
limiting the number of samples available for analysis. It is possible that some of this loss 
was due to extrarenal effects of TCE and iAs, as both are known to have effects on other 




aggression, a known issue with male mice in particular. As described in Section 2, 
efforts were made to limit conspecific aggression that has the potential to cause losses. 
Another limitation is that there is very little data on expected age-related or 
background lesions in the specific strains of mice used as the parental background strains 
in the present study, and there is no information regarding crosses derived from these 
strains.  
Potentially, the decision to deliver iAs in food instead of the usual vehicle, 
drinking water may be a limitation. This was done to mimic ingestion of low doses of 
iAs in food, but might alter the absorption, distribution, metabolism, and excretion 
characteristics of iAs. In addition, we wished to use food for one toxicant and water for 
delivery of the other. Because iAs is better documented as a contaminant of food than 
TCE, we decided to use food as the vehicle for iAs and water for TCE.  
In addition, other potential biomarkers of renal disease could have been chosen, 
including one of the classical markers, serum creatinine, and one of the newer 
biomarkers, KIM-1. Due to the limited volume of blood available, it was difficult to 
obtain the volumes of serum necessary to measure creatinine as well as other serum 
analytes. The test panel used for serum clinical chemistry was not sensitive enough to 
detect creatinine levels in the volume of sample available. For this reason, we chose to 
use BUN as our classical serum marker of renal disease. In many cases, urine volumes 
were limited as well. While multiplex assays for urinary biomarkers are available, they 
were considered cost-prohibitive for a study this large, and one urinary biomarker was 
chosen to accompany measurements of urinary creatinine, osmolality, and protein. 
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Because elevated NGAL has been associated with both acute renal injury and chronic 
kidney disease, we chose this biomarker. 
Despite the limitations of the study, this model more accurately reflects human 
exposure conditions by including multiple environmental toxicants, genetic 
heterogeneity, and long exposure to the toxicants. Despite this more accurate modeling 
of toxicant exposure, no evidence of increased damage from combination exposure was 
observed. Instead, there was evidence of increased damage due to iAs exposure, and no 
increase in damage with combination exposure. This may be due to damage from the 
second toxicant being limited by damage from the first being severe enough to 
necessitate regenerative responses in the renal tubular epithelium, such that a threshold 
of damage was reached. It is possible that the toxicants had antagonistic effects, although 
more analysis would be required to confirm this. More studies of combined toxicant 
exposure in genetically heterogeneous populations are needed, and it is likely that the 
effects of different toxicants in combination will have differing outcomes. 
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4. CONCLUSIONS
4.1. Modeling of Biological Response to Toxicant Exposure 
TCE and iAs are environmental toxicants that target the kidney as well as other 
organs. Chronic exposure to these toxicants has been associated with various renal health 
effects including development of clear cell renal cell carcinoma in humans with chronic 
exposure to TCE and chronic kidney disease with exposure to either of these toxicants. 
Specific responses to toxicant exposure is influenced by many factors other than just the 
toxicant itself. These factors include intrinsic (genetic and epigenetic variation, age and 
life stage, sex) and extrinsic factors (co-exposures to other toxicants, nutritional state, 
stressors, dosage, co-morbidities) (Zeise, et al., 2013). 
Development of a rodent model for renal cancer and disease development due to 
toxicant exposure is complicated by differences in renal handling of toxicants between 
rodents and humans as well as the tendency of rodents to develop significant background 
spontaneous renal disease that may mimic pre-neoplastic disease or mask more subtle 
lesions. In addition, classical toxicological studies often focus on one potential toxicant 
in a genetically homogeneous population, in contrast to the more typical exposure 
situation that involves genetically heterogeneous populations and exposure to mixtures 
of toxicants. 
Given these challenges, it has become clear that toxicological studies must 
address the effects of genetic variability and the range of sensitivity to toxicity due to 
this inherent variability. Experimental paradigms that assess and control for as many of 
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the intrinsic and extrinsic factors influencing renal response to toxicant exposure are also 
needed. Human epidemiological studies often lack detail regarding exposure levels, 
potential for co-exposure to toxicants, chronicity of exposure, or other potential risk 
factors including smoking or obesity. In an effort to address these limitations, a mouse 
model was devised that included genetic heterogeneity, mixtures of toxicants at 
environmentally relevant concentrations, and a diet that reflects a typical western diet to 
better reflect the exposure conditions of human populations. 
Primary renal cell tumors were not observed in this study. It is possible that there 
were too few mice in the study to detect this effect, given the rarity of the tumors even in 
exposed human populations. Despite the lack of primary renal tumor development in this 
study, evidence of differences in renal disease were observed among the different 
treatment groups. 
Increases in tubular disease scores between animals exposed to TCE alone, 
exposed to iAs alone, and those exposed to both toxicants were observed, although no 
difference in severity was observed in co-exposed animals, contrary to our expectations. 
The strongest pattern in the parameters evaluated was that male mice had higher 
evidence of renal disease than female mice. Both of these patterns largely held across 
histologic examination. Individual lesions that were increased in toxicant-exposed 
animals compared to unexposed included pelvic cellular infiltrates, tubular degeneration 
and regeneration, tubular dilation in the outer stripe of the outer medulla, and tubular 
epithelial vacuolation. The only individual lesion score that was higher in animals 
exposed to both toxicants than in unexposed animals was tubular epithelial vacuolation, 
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although, similar to the tubular disease score results, no difference was observed for this 
between combination exposure and single toxicant exposure. 
As detailed in Section 3, evaluation of BUN, urinary NGAL, and UPC showed 
no strong pattern in response to toxicant exposure except that, like in the histological 
parameters, male mice had overall higher levels than female mice. Urinary NGAL, 
serum BUN, and UPC ratio were all higher in male mice than in female mice when all 
mice were considered. 
In contrast, urinary NGAL levels were not different in single or combination 
exposed animals across the study. Increased BUN was observed in animals exposed to 
As alone when single or co-exposure was examined. Among the individual treatment 
groups, BUN was higher in the Low As/No TCE and High As/No TCE group. UPC ratio 
was higher in the Low As/High TCE group and the High As/No TCE group. The 
common factor among these parameters was As exposure. Exposure to TCE appears to 
have had little effect on the biomarkers. In some cases, there were very few samples 
from male mice to evaluate, and so it is possible that there simply was not enough power 
to detect effects for some of these measurements, and this may have affected our ability 
to detect significant differences with these parameters even had there been a difference. 
 It is possible that damage caused by one toxicant was not increased by exposure 
to a second renal toxicant as the cells already damaged by the first toxicant to the point 
of requiring regeneration would not be further damaged by the second toxicant. 
Moderate correlation was observed between several histologic parameters, BUN, 
and urinary NGAL despite the lack of significant differences between treatment groups 
75 
with urinary NGAL. The tubular disease score and BUN had the highest correlation 
among the measured parameters and a similar degree of positive correlation was 
observed between BUN and kidney weight/body weight ratio. It is speculated that the 
correlation between these measurements may be related to the significant increase in 
BUN, kidney weight/body weight ratio, urinary NGAL, and UPC in male mice across 
the study, rather than related to the toxicant exposure. 
Despite efforts to increase the carcinogenic potential of the renal toxicants in the 
study by including two toxicants whose primary target is the kidney at varying doses 
over a long period of time, no primary renal tubular neoplasms developed. Given the 
results observed, it appears that iAs is the greater contributor to renal damage in our 
study, and this is possibly because efforts were made to alter the renal handling of heavy 
metals by knocking out the MDR1 gene in these mice. As previously stated, this has 
been shown to increase renal accumulation of heavy metals in mice. On the other hand, 
the renal handling of TCE was not modified, partially because its handling is complex 
and not fully elucidated, so it is difficult to pick a single target. Instead, the inclusion of 
iAs as a second toxicant was intended to potentially create an additive or synergistic 
effect that would increase the carcinogenicity and renal damage effects of TCE. In the 
present study, this effect was not observed. 
Despite the limitations of the study, discussed in detail in previous Sections, this 
model more accurately models human exposure conditions. Unfortunately, even with 
this more accurate modeling, no renal cancers developed, and evidence of increased 
renal damage in response to co-exposure to toxicants was not observed. There was some 
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evidence of reduced or equal damage from co-exposure, and we speculate that this is due 
to a threshold effect of damage from a first toxicant limiting the ability of a second 
toxicant to cause damage or early loss of animals that might have had increased damage, 
limiting our ability to detect increased damage. Additional studies of combined toxicant 
exposure are needed, and since the inception of the present study, new genetic mouse 
resources have been developed that may help in future studies. 
4.2. Future Work 
The development of the genetically heterogeneous mice used in this project was 
time, cost, and labor intensive, and generated a large number of mice that were not used 
for the study protocol. While this method of generating mice for the present study was 
appropriate at the time, newer, less labor- and time-intensive mouse model resources are 
now available. A recent review article (Harrill et al., 2017) has provided an overview of 
the various mouse resources currently available. Briefly, the main mouse populations 
available are the classic inbred strains, conventional outbred stocks, Mouse Diversity 
Panel (MDP), Collaborative Cross (CC), and Diversity Outbred (DO) models. 
At the time that the present study was begun, the Collaborative Cross (CC) panel 
of mice was still in development, (Churchill et al., 2004) and although development of 
additional CC strains continues, there are now a number of CC strains available that 
enable study of complex traits on a genetically heterogeneous but well-characterized 
mouse model. Indeed, recently, the first toxicological study utilizing CC mice was 
published (Cichocki, et al., 2017), indicating that there is a large amount of variability 
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among the CC strains in metabolism and response to tetrachloroethylene, a molecule 
related to TCE. This result strengthens the argument for use of genetically 
heterogeneous, but defined mouse models such as the CC mice to predict the variability 
in human sensitivity to toxicants. 
Future development of a mouse model of human toxicant-induced clear cell renal 
cell carcinoma may utilize one of the newer mouse model resources designed to help 
study the genetic influences on multifactorial diseases. In addition, further elucidation of 
the differences in metabolism of TCE in mice versus humans, and the genes involved in 
this process, may provide avenues for manipulation of the mouse to more accurately 
reflect the metabolic process as it exists in humans and the toxic metabolite profile that 
results in the development of renal tumors due to TCE exposure. 
One possibility for further genetic study using the present model and existing 
data is the use of quantitative trait locus (QTL) analysis on the animals that had 
exaggerated responses compared to the animals that had muted responses to toxicant 
exposure to elucidate potential genes involved in this response. Examining the data from 
BUN, histologic scoring, and urinary NGAL, it is observed that in each category there is 
a subset of individuals with evidence of relatively extreme values for these analytes, 
indicating renal disease (Figures 4.1, 4.2, and 4.3a and 4.3b). 
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Figure 4.1 BUN Extreme Responders 
Outliers determined by Tukey method.  
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Figure 4.2 Tubular Disease Score Extreme Responders 





Figure 4.3 Urinary NGAL Normalized to Creatinine Extreme Responders. 
Outliers determined by Tukey method. A) Actual values plotted. One value skews the 
graph. B) Values plotted on a log 10 scale.  
 
 
When these extreme responders are compared, there is some overlap between 
categories (Figure 4.4). This extreme response may be used as a phenotype (trait) for 
QTL analysis. Single nucleotide polymorphism (SNP) sequencing has been performed 
and QTL analyses will be performed in future studies to examine the potential for 
genetic influence on these differences in response.  
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Figure 4.4 Overlap in Extreme Responders for Tubular Disease, BUN, and NGAL. 
Overlap among extreme responders in the three categories.  
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